Patents by Inventor Ye-Lim Lee

Ye-Lim Lee has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • CRYSTALLINE FORM OF HETEROCYCLIC COMPOUND AS PROTEIN KINASE INHIBITOR
    Publication number: 20240051957
    Abstract: The present invention relates to a crystalline form of the heterocyclic compound N-(4-(1-(2-cyanoacetyl)-3-methyl-1,2,3,6-tetrahydropyridin-4-yl)-1H-pyrrolo[2,3-b]pyridin-6-yl)cyclopropanecarboxamide as a protein kinase inhibitor.
    Type: Application
    Filed: March 16, 2022
    Publication date: February 15, 2024
    Inventors: Young Ju Kim, Jun Kim, Hanna Kim, Jae Hong Kweon, Ye-Lim Lee, Do Seok Hwang
  • Heterocyclic compound as a protein kinase inhibitor
    Patent number: 11524968
    Abstract: The present invention provides a novel compound having a protein kinase inhibition activity, a stereoisomer thereof or a pharmaceutically acceptable salt thereof. The compound, the stereoisomer thereof or the pharmaceutically acceptable salt thereof according to the present invention show a protein kinase inhibition activity, thus being effective in preventing or treating diseases related to protein kinase, such as cancer, autoimmune disease, neurological disease, metabolic disease, infection or the like.
    Type: Grant
    Filed: October 17, 2018
    Date of Patent: December 13, 2022
    Assignee: HK inno.N Corporation
    Inventors: Hyuk Woo Lee, Mi Kyung Ji, Seung Chan Kim, Ha Na Yu, Soo Yeon Jung, Ji-Yeon Park, Ye-Lim Lee, Ho-Youl Lee, So Young Ki, Dongkyu Kim, Myeongjoong Kim
  • Heterocyclic Compound as a Protein Kinase Inhibitor
    Publication number: 20210171544
    Abstract: The present invention provides a novel compound having a protein kinase inhibition activity, a stereoisomer thereof or a pharmaceutically acceptable salt thereof. The compound, the stereoisomer thereof or the pharmaceutically acceptable salt thereof according to the present invention show a protein kinase inhibition activity, thus being effective in preventing or treating diseases related to protein kinase, such as cancer, autoimmune disease, neurological disease, metabolic disease, infection or the like.
    Type: Application
    Filed: October 17, 2018
    Publication date: June 10, 2021
    Inventors: Hyuk Woo Lee, Mi Kyung Ji, Seung Chan Kim, Ha Na Yu, Soo Yeon Jung, Ji-Yeon Park, Ye-Lim Lee, Ho-Youl Lee, So Young KI, Dongkyu Kim, Myeongjoong Kim